e-learning
resources
ERJ
2009
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Animal models of ventilator-associated pneumonia
Luna C. M., Sibila O., Agusti C., Torres A.
Source:
Eur Respir J 2009; 33: 182-188
Journal Issue:
January
Disease area:
Respiratory critical care, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Luna C. M., Sibila O., Agusti C., Torres A.. Animal models of ventilator-associated pneumonia. Eur Respir J 2009; 33: 182-188
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Animal models of VAP
Source: Eur Respir Mon 2011; 53: 98-112
Year: 2011
Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia
Source: Eur Respir J 2011; 37: 1332-1339
Year: 2011
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
Source: Eur Respir J, 50 (3) 1700582; 10.1183/13993003.00582-2017
Year: 2017
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
Source: Guideline 2017
Year: 2017
Pharmacokinetic optimisation of β-lactams for the treatment of ventilator-associated pneumonia
Source: Eur Respir Rev 2007; 16: 45-49
Year: 2007
VAP prevention: pharmacological strategies
Source: Eur Respir Mon 2011; 53: 74-82
Year: 2011
Challenges in the management of hospital-acquired pneumonia including ventilator-associated pneumonia
Source: ERS Course 2018 - Respiratory Infections
Year: 2018
Evidence on measures for the prevention of ventilator-associated pneumonia
Source: Eur Respir J 2007; 30: 1193-1207
Year: 2007
Ventilator-associated pneumonia due to colistin susceptible-only microorganisms
Source: Eur Respir J 2007; 30: 307-313
Year: 2007
New approaches to the aetiological diagnosis of VAP
Source: Eur Respir Mon 2011; 53: 11-23
Year: 2011
Respiratory infections in the immunocompetent host: from asthma exacerbations to hospital-acquired pneumonia
Source: Annual Congress 2007 - Infections year in review
Year: 2007
Microbial investigation in ventilator-associated pneumonia
Source: Eur Respir J 2001; 17: 791-801
Year: 2001
How to prevent ventilator-associated pneumonia
Source: Annual Congress 2013 –PG3 Infections and critical patients: emerging problems and clinical strategies
Year: 2013
Relationship between tracheotomy and ventilator-associated pneumonia: a case control study
Source: Eur Respir J 2007; 30: 314-320
Year: 2007
Diagnosis and treatment of nosocomial pneumonia in ALI/ARDS patients
Source: Eur Respir J 2003; 22: 77S-83S
Year: 2003
Characterization of pulmonary function and mechanics in a novel model of pneumococcal pneumonia
Source: International Congress 2015 – Prognostic factors in pneumonia: from clinical observations to experimental models
Year: 2015
Impact of guidelines on HAP and VAP outcomes
Source: Eur Respir Mon 2011; 53: 66-73
Year: 2011
Ventilator-associated pneumonia (VAP): epidemiology, empirical treatment and outcome
Source: Eur Respir J 2005; 26: Suppl. 49, 188s
Year: 2005
Use of ceftriaxone/sulbactame for treatment of mild-to-severe community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Treatment of airways disease
Year: 2009
Implications of identifying the pathogen in ventilator-associated pneumonia (VAP)
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept